A Phase I/II Study of Cediranib (AZD2171) in Japanese Metastatic Colorectal Cancer Patients in Combination With FOLFOX

Clinical trial NCT00494221 · COMPLETED

Trial details

NCT number: NCT00494221
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2007-06-01
Primary completion: 2009-10-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.